Cancer is one of the most challenging diseases and up until now. One of the most challenging things about cancer treatment is not the cure itself but the differentiation between the tumor cells and the normal cells. Most of the medical treatments of the cancer today cannot differentiate between the cancer cells and the normal one as well as it damages the hall tissue and it is still considered as a low-effect treatment to be applied in cancer. One of the most popular treatments of this kind is chemotherapy which is known for damaging the hall cells, cancer, and normal ones.
Dina Saeed Solitah, Mustafa Ashraf Salah (2020); The effect of using the monoclonal antibodies of the protein ErbB-2 antigen on the lung cancer patients; International Journal of Scientific and Research Publications (IJSRP)
10(11) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.10.11.2020.p10758